title: Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis.
abstract: Progressive weakness remains the clinical hallmark of amyotrophic lateral sclerosis (ALS). Accordingly, a variety of tools has been developed to capture this disease feature, including questionnaires, such as the ALS-functional rating scale, strength testing, pulmonary function tests, electrophysiologic measures, including motor unit number estimation, and imaging techniques. Despite this plethora of approaches, there is little agreement as to what measures to use in a given clinical trial or in the clinic during routine patient care. Part of the reason for this uncertainty is that ALS is a remarkably protean disease. Some individuals progress rapidly, others slowly; some patients have considerable upper motor neuron dysfunction, whereas others have little; and there is considerable variation in the sequence of body regions affected, in some the disease beginning in the bulbar musculature and in others in one arm or one leg. Here, I present a variety of basic and more complex clinical measures for potential use in therapeutic trials with the aim of offering a balanced and practical set of recommendations, as well as considerations for future studies.
authors.affiliation: Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA, 02215, USA, srutkove@bidmc.harvard.edu.
authors.forename: Seward B
authors.initials: SB
authors.lastname: Rutkove
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy*; D000818:Animals; D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid; D018450:Disease Progression; D018737:Hand Strength; D006801:Humans; D008279:Magnetic Resonance Imaging; D009420:Nervous System / Q000503:physiopathology; D009431:Neural Conduction / Q000502:physiology; D017063:Outcome Assessment, Health Care / Q000379:methods*; D012120:Respiration Disorders / Q000209:etiology; D011795:Surveys and Questionnaires
chemical_list: D015415:Biomarkers